Cutera is launching the Cutera Residency Program, a new program designed to expand access to AviClear, a 1726nm laser for the long-term treatment of mild, moderate, and severe acne, into dermatology training programs across North America.
This new program aims to integrate AviClear into the curriculum at academic institutions.
The program establishes a 24-month partnership that includes technology integration and structured clinical training. Alongside education, it creates collaboration opportunities on publications, research, podium presentations, and exploration of new clinical indications. The program also creates pathways to Cutera’s broader technology portfolio.
“Residents will now have early access to cutting-edge technology like AviClear, giving them hands-on experience with the future of acne care,” says Ashish C. Bhatia, MD, FAAD, Co-Director of Dermatologic, Laser and Cosmetic Surgery at Oak Dermatology in Naperville, IL. “At the same time, this partnership opens the door to exciting new research opportunities into sebaceous-based conditions such as sebaceous hyperplasia and hidradenitis suppurativa, expanding what’s possible in dermatologic care.”
Cutera is currently accepting applications from universities and programs interested in joining the Cutera Residency Program. Interested parties can apply and learn more by emailing residency@cutera.com.
